All News

Canadian cannabis producer, MediPharm Labs, has exported oil which contains CBD and THC to the US to be used in a clinical trial.

On Wednesday, August 30th, the Department of Health and Human Services made its recommendation to the Drug Enforcement Agency to classify cannabis as a Schedule III drug, paving the way for reform, industry expansion, and research opportunities.

A recent study sought to examine the occurrence of cannabis use disorder in patients and recreational users, specifically in a state with legal cannabis access.

In a recent article, our sister publication, Nutritional Outlook, delves into the controversial delta-8 THC hemp cannabinoid and why it is such a hot topic right now.

The recently approved legislation creates new opportunities for possession and cultivation.

Our sister publication, Nutritional Outlook, recently discussed Apex Compliance's latest new software detects risky marketing terms and phrases and suggests lower-risk alternatives.

Argentina’s latest cannabis law established new regulations for its cannabis industry framework.

Minnesota’s St. Cloud State University and Green Flower cannabis company recently announced new online cannabis certificate programs.

The study noted high levels of substance use in certain age groups compared to previous years.

New Jersey announces plans to allocate $5 million in funding from cannabis revenue towards Community-Based Violence Intervention (CBVI) programs throughout the state.

Workers at a medical and recreational cannabis cultivation facility in Connecticut recently voted to unionize.

Learn more about how our Canna Boot Camp will educate attendees on the latest advancements in the cannabis industry in an interactive, workshop setting.

Our sister publication, LCGC, recently covered updates on the new mobile HPLC system for cannabis analysis selected by the Food and Drug Administration.

Ahead of anticipated FDA approval of psychedelic therapies, two organizations joined together to publish guidelines for practitioners.

Read coverage from our sister publication, Nutritional Outlook, on “The Hemp Access and Consumer Safety Act,” which was previously proposed in 2021.

Recent legislation creates a different approach to legal cannabis in the state.

Our sister publication, Pharmacy Times, recently published an article on quality standards and national regulation helping establish cannabis's role as medicine.

A recent lawsuit brought to the state’s Superior Court challenges the constitutionality of several aspects of cannabis sales.

Germany approved a plan in mid-August to legalize some recreational cannabis.

A recently published study tracked American adults’ opinions over several years on smoking cannabis compared to smoking tobacco.

Massachusetts proposes draft regulations that include agency’s Host Community Agreement oversight, municipal equity requirements, and suitability reform.

Though cannabis remains illegal for recreational purposes, cultivators can be issued licenses for producing fiber and seeds.

In a recently revealed email, the DEA is looking to consider Delta-8 THC products federally illegal if they are synthesized from CBD.

The seventh installment in the series looks at cannabis use in people over 50 years old, the stigma surrounding cannabis use, and the concept of ‘plants over pills.’

With Minnesota’s recent cannabis legalization, White Earth Nation, gets involved in the cannabis industry through their medical cannabis program and implementation of adult-use sales.

The small study will begin later this year and seeks to further understand brain function in gambling disorder.

A recent economic report details how cannabis businesses in Texas have grown in revenue more than $8B.

Recent coverage highlighted how banking and social equity in the cannabis industry are connected.

The recent legislation addresses THC limit, licenses, and extracts.

Our sister publication, dvm360, recently published breakthrough research from a study involving CBD+CBDA oil as a potential treatment for atopic dermatitis in dogs.